Guanabenz Acetate
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 317126

CAS#: 23256-50-0

Description: Guanabenz acetate is an α2A-AR adrenergic agonist and IGRS (imidazoline I2 binding site) selective ligand. Guanabenz acetate is an activator of alpha2B-AR (α2b-adrenergic receptor) and alpha2C-AR (α2c-adrenergic receptor). It is also used as an antihypertensive drug to treat high blood pressure.


Chemical Structure

img
Guanabenz Acetate
CAS# 23256-50-0

Theoretical Analysis

MedKoo Cat#: 317126
Name: Guanabenz Acetate
CAS#: 23256-50-0
Chemical Formula: C10H12Cl2N4O2
Exact Mass:
Molecular Weight: 291.13
Elemental Analysis: C, 41.26; H, 4.15; Cl, 24.35; N, 19.24; O, 10.99

Size Price Shipping out time Quantity
25mg USD 160 2 Weeks
50mg USD 180 2 Weeks
100mg USD 210 2 Weeks
200mg USD 250 2 Weeks
500mg USD 350 2 Weeks
1g USD 450 2 Weeks
2g USD 650 2 Weeks
Inquire bulk and customized quantity

Pricing updated 2021-03-05. Prices are subject to change without notice.

Guanabenz acetate, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.

Synonym: Wytensin, WY-8678, WY 8678, WY8678, EIPA

IUPAC/Chemical Name: [(2,6-Dichlorobenzylidene)amino]guanidine acetate

InChi Key: MCSPBPXATWBACD-GAYQJXMFSA-N

InChi Code: InChI=1S/C8H8Cl2N4.C2H4O2/c9-6-2-1-3-7(10)5(6)4-13-14-8(11)12;1-2(3)4/h1-4H,(H4,11,12,14);1H3,(H,3,4)/b13-4+;

SMILES Code: NC(N/N=C/C1=C(Cl)C=CC=C1Cl)=N.CC(O)=O

Appearance:
White to off-white solid powder.

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO, not in water

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:
2934.99.9001

Handling Instructions:

Preparing Stock Solutions

The following data is based on the product molecular weight 291.13 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Igaki N, Yamada H, Oimomi M, Kasuga M. The effective inhibition of the Maillard reaction by guanabenz acetate, and its relevance to the prevention of diabetic complications. Clin Chim Acta. 1991 May 31;199(1):113-5. PubMed PMID: 1934497.

2: Kotake H, Kinugawa T, Hirai S, Matsumoto T, Fukuki M, Hasegawa J, Mashiba H. Effects of guanabenz acetate on the pacemaker activity of rabbit sinoatrial node cells. Arch Int Pharmacodyn Ther. 1989 Jul-Aug;300:209-17. PubMed PMID: 2619423.

3: Spritzer N, Spritzer TS, Rodrigues R. [Guanabenz acetate and serum lipids. Sequential evaluation during one year]. Arq Bras Cardiol. 1988 Aug;51(2):193-7. Portuguese. PubMed PMID: 3075114.

4: LaRusso P, Jessup SA, Rogers FJ, Rogers JC. Sinoatrial and atrioventricular dysfunction associated with the use of guanabenz acetate. Can J Cardiol. 1988 Apr;4(3):146-8. PubMed PMID: 3378199.

5: Harvengt C. Drugs recently released in Belgium. Guanabenz acetate, isotretinoin and etretinate. Acta Clin Belg. 1986;41(1):60-3. PubMed PMID: 3458348.

6: Tennant FS Jr, Rawson RA. Guanabenz acetate: a new, long-acting alpha-two adrenergic agonist for opioid withdrawal. NIDA Res Monogr. 1984 Mar;49:338-43. PubMed PMID: 6090917.

7: Capuzzi DM, Cevallos WH. Inhibition of hepatic cholesterol and triglyceride synthesis by guanabenz acetate. J Cardiovasc Pharmacol. 1984;6 Suppl 5:S847-52. PubMed PMID: 6084138.

8: Grenfell RF. Double-blind study of guanabenz acetate in hypertensive patients. South Med J. 1983 Feb;76(2):199-201. PubMed PMID: 6337405.